Company Filing History:
2 out of 470 
1 out of 380 
1 out of 1 Years Active: 2020-2024
Title: Nejat Egilmez: Innovator in Cancer and Inflammation Treatment
Introduction
Nejat Egilmez is a prominent inventor based in Louisville, KY (US). He has made significant contributions to the fields of cancer and inflammation treatment through his innovative research and patented technologies. With a total of 3 patents, his work focuses on developing effective therapeutic compositions.
Latest Patents
Egilmez's latest patents include groundbreaking methods for treating inflammation and cancer. One of his notable inventions involves compositions and methods that utilize a combination of interleukin-10 (IL-10) and interleukin-12 (IL-12) to address cancer and inflammatory diseases. Additionally, he has developed a method that combines an anti-PD-1 antibody and an anti-IL-17 antibody for cancer treatment. Another significant patent pertains to compositions for stabilizing and delivering proteins. This invention discloses methods for embedding bioactive agents in a crystalline matrix, enhancing their stability compared to other microparticulate or nanoparticulate agents.
Career Highlights
Throughout his career, Nejat Egilmez has worked with esteemed institutions such as Brown University and the University of Louisville Research Foundation, Inc. His research has been pivotal in advancing therapeutic strategies for complex diseases.
Collaborations
Egilmez has collaborated with notable colleagues, including Edith Mathiowitz and Stacia Furtado, who have contributed to his research endeavors.
Conclusion
Nejat Egilmez's innovative work in the treatment of cancer and inflammation showcases his dedication to improving healthcare through scientific advancements. His patents reflect a commitment to developing effective therapies that can make a significant impact in the medical field.